HIV infection and cardiovascular pathology
暂无分享,去创建一个
[1] N. Koziolova,et al. Contribution of inflammation to heart failure development in human immunodeficiency virus-infected patients , 2022, Russian Journal of Cardiology.
[2] Arjun Sinha,et al. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV. , 2020, Progress in cardiovascular diseases.
[3] Н. А. Козиолова,et al. Особенности формирования хронической сердечной недостаточности у больных, инфицированных вирусом иммунодефицита человека , 2020 .
[4] D. Duplyakov,et al. Coronary Heart Disease in HIV-Infected Patients , 2020, Rational Pharmacotherapy in Cardiology.
[5] Steven C. Johnson,et al. Examining Mortality To Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center. , 2019, AIDS research and human retroviruses.
[6] T. Neilan,et al. Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations , 2019, Current HIV/AIDS Reports.
[7] M. Budoff,et al. HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study. , 2019, AIDS Research and Human Retroviruses.
[8] D. Lloyd‐Jones,et al. Ventricular Ectopy and Arrhythmia Characteristics for Persons Living with HIV and Uninfected Controls , 2019, Journal of the International Association of Providers of AIDS Care.
[9] R. Greenblatt,et al. HIV infection is an independent risk factor for decreased 6-minute walk test distance , 2019, PloS one.
[10] S. Cyr,et al. Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients With HIV Infection. , 2019, The Canadian journal of cardiology.
[11] F. Violi,et al. Atrial fibrillation and human immunodeficiency virus type‐1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy , 2019, British journal of clinical pharmacology.
[12] Н. А. Козиолова,et al. ВИЧ-АССОЦИИРОВАННАЯ ПАТОЛОГИЯ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ , 2019 .
[13] A. Mocumbi,et al. Need for active cardiovascular screening in HIV-infected children under antiretroviral therapy in Africa. , 2019, Cardiovascular diagnosis and therapy.
[14] H. Bang,et al. Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening , 2019, Journal of the International Association of Providers of AIDS Care.
[15] Katherine C. Wu,et al. Predictors of electrocardiographic QT interval prolongation in men with HIV , 2018, Heart.
[16] T. Neilan,et al. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure. , 2018, Journal of the American College of Cardiology.
[17] Yanan Jiang,et al. The role of HIV Tat protein in HIV-related cardiovascular diseases , 2018, Journal of Translational Medicine.
[18] D. Lloyd‐Jones,et al. Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls , 2018, PloS one.
[19] S. Colan,et al. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study. , 2017, Journal of the American College of Cardiology.
[20] G. d’Ettorre,et al. Cardiovascular risk and dyslipidemia among persons living with HIV: a review , 2017, BMC Infectious Diseases.
[21] Xinguang Chen,et al. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. , 2017, Journal of the American Society of Hypertension : JASH.
[22] Olga V. Patterson,et al. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study , 2017, JAMA cardiology.
[23] J. C. A. Lacson,et al. HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease , 2017, Current Atherosclerosis Reports.
[24] E. Wing. HIV and aging. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[25] A. Lonardo,et al. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV , 2016, World journal of gastroenterology.
[26] U. Hoffmann,et al. HIV Infection and Heart Failure Outcomes in Women. , 2016, Journal of the American College of Cardiology.
[27] E. Bahiru,et al. Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013. , 2016, The American journal of cardiology.
[28] M. Myerson,et al. Management of lipid disorders in patients living with HIV , 2015, Journal of clinical pharmacology.
[29] G. Adler,et al. RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients. , 2015, The Journal of clinical endocrinology and metabolism.
[30] D. Lloyd‐Jones,et al. A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients. , 2015, The American journal of cardiology.
[31] B. Nordestgaard,et al. Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] K. Sliwa,et al. HIV and the heart: the impact of antiretroviral therapy: a global perspective. , 2013, European heart journal.
[33] F. Gaita,et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. , 2013, European heart journal.
[34] E. Vittinghoff,et al. Sudden cardiac death in patients with human immunodeficiency virus infection. , 2012, Journal of the American College of Cardiology.
[35] F. Gaita,et al. Coronary artery disease Acute coronary syndromes in human immunodeficiency virus patients : a meta-analysis investigating adverse event rates and the role of antiretroviral therapy , 2012 .
[36] E. Soliman,et al. Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study. , 2011, Journal of electrocardiology.
[37] De-Li Dong,et al. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs. , 2011, Journal of molecular and cellular cardiology.
[38] L. Kuller,et al. Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. , 2011, Archives of internal medicine.
[39] D. Jacobs,et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.
[40] A. Barbagelata,et al. Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem , 2009, Current cardiology reviews.
[41] Lewis H Kuller,et al. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.
[42] Hang Lee,et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.
[43] John T Brooks,et al. Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.
[44] R. Pandey,et al. Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India. , 2006, International journal of cardiology.
[45] M. Bukrinsky,et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.